# MBX Biosciences, Inc.: Form 8-K, filed Jan 7, 2025

- Company: [MBX Biosciences, Inc.](/companies/mbx.md) (CIK 1776111)
- Form: 8-K
- Filed: 2025-01-07
- Accepted by EDGAR: Jan 7, 2025, 07:21 ET
- Period: 2025-01-07
- Accession: 0000950170-25-002555
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1776111/000095017025002555/mbx-20250107.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1776111/000095017025002555/

## Items reported

- Item 2.02: Results of operations
- Item 7.01: Regulation FD disclosure
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1776111/000095017025002555/mbx-20250107.htm

Filed Jan 7, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-002555. Last ingested by Listed: Nov 4, 2026, 15:47 ET. No prices; not investment advice.